Exposure Notification
Exposure Notification is a digital service developed to aid in the containment of infectious diseases, such as COVID-19. It is a form of contact tracing that uses Bluetooth technology to detect when users have been in close proximity to each other, thus potentially exposing them to the disease.
Overview[edit | edit source]
The Exposure Notification system was first introduced by Apple and Google in response to the COVID-19 pandemic. The system is designed to preserve user privacy while alerting individuals of potential exposure to the virus. It uses Bluetooth Low Energy (BLE) to exchange anonymous identifier beacons with nearby devices.
Functionality[edit | edit source]
When two devices with the Exposure Notification system enabled are in close proximity, they exchange anonymous identifier beacons. These beacons change frequently to prevent tracking. If a user tests positive for the disease, they can choose to upload their device's beacons to a central server. Other devices periodically download these beacons and compare them to the ones they have encountered. If there is a match, the user is notified of their potential exposure.
Privacy[edit | edit source]
Privacy is a key aspect of the Exposure Notification system. The system is designed to be decentralized, meaning that matching of beacons is done on the user's device and not on a central server. Furthermore, the system does not collect location data or personally identifiable information. The identifiers exchanged are random and change frequently to prevent tracking.
Adoption[edit | edit source]
Several countries and regions have adopted the Exposure Notification system as part of their efforts to contain the spread of COVID-19. These include, but are not limited to, Germany, Ireland, and several states in the United States.
Criticism[edit | edit source]
Despite its potential benefits, the Exposure Notification system has faced criticism. Some critics argue that the system's effectiveness is limited by the number of people who choose to use it. Others raise concerns about potential misuse of the system, despite the privacy measures in place.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
